Preoperative Cardiac Risk Assessment for Noncardiac Surgery in Patients with Heart Failure

Papers of particular interest, published recently, have been highlighted as: • Of importance

1. 1.
   Heart Disease and Stroke Statistics—2011 Update. A Report from the American Heart Association. Circulation. 2011;123:e18–209.Google Scholar
2. 2.
   US Census Data. 2008 projections. Projections of the Population by Selected Age Groups and Sex for the United States 2010 to 2050. Available at: http://www.census.gov/population/www/projections/summarytables.html. Accessed October 10th 2012.
3. 3.
   National Hospital Discharge Survey: 2009 table, procedures by selected patient characteristics—number by procedure category and age. Accessed online: http://www.cdc.gov/nchs/fastats/insurg.htm.
4. 4.
   Goldman L, Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977;297:845–50.PubMedCrossRefGoogle Scholar
5. 5.
   Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–9.PubMedCrossRefGoogle Scholar
6. 6.
   • Hammill BG, Curtis LH, Bennett-Guerrero E, O’Connor CM, Jollis JG, Schulman KA, et al. Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology. 2008;108:559–67. Analysis of Medicare data from patients 65 years of age and older without end-stage renal disease undergoing major noncardiac surgery between 2000 and 2004. Of 159,327 procedures, 18 % were performed on patients with heart failure and 34 % on patients with coronary artery disease. Adjusting for type of procedure, demographics and comorbidities, patients with heart failure had 63 % higher mortality and 51 % higher 30-day readmission compared to patients without heart failure or coronary artery disease.PubMedCrossRefGoogle Scholar
7. 7.
   van Diepen S, Bakal JA, McAlister FA, Ezekowitz JA. Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38047 patients. Circulation. 2011;124:289–96.PubMedCrossRefGoogle Scholar
8. 8.
   Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Executive summary of the ACC/AHA Task Force report: guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Anesth Analg. 1996;82:854–60.Google Scholar
9. 9.
   Fletcher JP, Antico VF, Gruenewald S, Kershaw LZ. Risk of aortic aneurysm surgery as assessed by preoperative gated heart pool scan. Br J Surg. 1989;76:26–8.PubMedCrossRefGoogle Scholar
10. 10.
    Rohde LE, Polanczyk CA, Goldman L, Cook EF, Lee RT, Lee TH. Usefulness of transthoracic echocardiography as a tool for risk stratification of patients undergoing major noncardiac surgery. Am J Cardiol. 2001;87:505–9.PubMedCrossRefGoogle Scholar
11. 11.
    Halm EA, Browner WS, Tubau JF, Tateo IM, Mangano DT. Echocardiography for assessing cardiac ris in patients having noncardiac surgery. Study of Perioperative Ischemic Research Group. Ann Intern Med. 1996;125:433–41.PubMedGoogle Scholar
12. 12.
    Xu-Cai YO, Brotman DJ, Phillips CO, Michota FA, Tang WH, Whinney CM, et al. Outcomes of patients with stable heart failure undergoing elective noncardiac surgery. Mayo Clin Proc. 2008;83:280–8.PubMedCrossRefGoogle Scholar
13. 13.
    • Healy KO, Waksmonski CA, Altman RK, Stetson PD, Reyentovich A, Maurer MS. Perioperative outcome and long term mortality for heart failure patients undergoing intermediate and high risk noncardiac surgery: impact of left ventricular ejection fraction. Congest Heart Fail. 2010;16(2):45–9. Single center investigation of 174 pts with heart failure prior to elective or urgent, but not emergent, intermediate or major noncardiac surgery stratified by ejection fraction. Following multivariate adjustment, severely reduced ejection fraction (<30 %) was associated with adverse perioperative events. Age >80 years and history of diabetes were also independent risk factors for adverse events.Google Scholar
14. 14.
    Dernellis J, Panaretou M. Assessment of cardiac risk before noncardiac surgery: brain natriuretic peptide in 1590 patients. Heart. 2006;92:1645–50.PubMedCrossRefGoogle Scholar
15. 15.
    Villacorta Junior H, Castro IS, Godinho M, Mattos C, Visconti R, Saud M, et al. B-type natriuretic peptide is predictive of postoperative events in orthopedic surgery. Arq Bras Cardiol. 2010;95(6):743–8.PubMedCrossRefGoogle Scholar
16. 16.
    Feringa HHH, Bax JJ, Elhendy A, de Jonge R, Lindemans J, Schouten O, et al. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. Am J Cardiol. 2006;98(1):111–5.PubMedCrossRefGoogle Scholar
17. 17.
    Schutt RC, Cevik C, Phy MP. Plasma N-terminal prohormone brain natriuretic peptide as a marker for postoperative cardiac events in high-risk patients undergoing noncardiac surgery. Am J Cardiol. 2009;104(1):137–40.PubMedCrossRefGoogle Scholar
18. 18.
    • Ryding AD, Kumar S, Worthington AM, Burgess D. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis. Anesthesiology. 2009;111(2):311–9. Meta-analysis of 15 prospective studies incorporating 4,856 subjects evaluating the association of natriuretic peptides (BNP or NT-proBNP) and postoperative major adverse cardiovascular events or mortality. Elevated BNP was associated with short-term cardiovascular events (OR 19.77; 95 % CI: 13.2-29.7), all-cause mortality (OR 9.28, CI 3.51-24.65), and cardiac death (OR 23.88, CI 9.43-60.43). Results were similar for NT-proBNP.PubMedCrossRefGoogle Scholar
19. 19.
    Boersma E, Poldermans D, Bax JJ, Steyerberg EW, Thomson IR, Banga JD, et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA. 2001;285:1865–73.PubMedCrossRefGoogle Scholar
20. 20.
    L’Italien GJ, Paul SD, Hendel RC, Leppo JA, Cohen MC, Fleisher LA, et al. Development and validation of a Bayesian model for perioperative cardiac risk assessment in a cohort of 1,081 vascular surgical candidates. J Am Coll Cardiol. 1996;27:779–86.PubMedCrossRefGoogle Scholar
21. 21.
    McPhail N, Calvin JE, Shariatmadar A, Barber GC, Scobie TK. The use of preoperative exercise stress testing to predict cardiac complications after arterial reconstruction. J Vasc Surg. 1988;7:60–8.PubMedGoogle Scholar
22. 22.
    Reilly DF, McNeely MJ, Doerner D, Greenberg DL, Staiger TO, Geist MJ, et al. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med. 1999;159:2185–92.PubMedCrossRefGoogle Scholar
23. 23.
    Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, et al. ACC/AHA guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. Circulation. 2007;116:e418–500.PubMedCrossRefGoogle Scholar
24. 24.
    • Older P, Smith R, Courtney P, Horn R. Preoperative evaluation of cardiac failure and ischemia in elderly patients by cardiopulmonary exercise testing. Chest. 1993;104:701–4. Prospective, observational evaluation of 187 elderly patients who underwent cardiopulmonary exercise testing prior to surgery. In all, 18 % of patients with an anaerobic threshold of <11 ml/min/kg died compared to 0.8 % of patients with an anaerobic threshold >11 ml/min/kg.PubMedCrossRefGoogle Scholar
25. 25.
    Mahdyoon H, Klein R, Eyler W, Lakier JB, Chakko SC, Gheorghiade M. Radiographic pulmonary congestion in end-stage congestive heart failure. Am J Cardiol. 1989;63:625–7.PubMedCrossRefGoogle Scholar
26. 26.
    Stevenson LW, Perloff JK. The limited reliability of physical sign for estimating hemodynamics in chronic heart failure. JAMA. 1989;261:884–8.PubMedCrossRefGoogle Scholar
27. 27.
    Chakko S, Woska D, Martinez H, de Marchena E, Futterman L, Kessler KM, et al. Clinical, radiographic and hemodynamic correlations in the chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med. 1991;90:353–9.PubMedGoogle Scholar
28. 28.
    Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American college of cardiology foundation/American heart association task force on practice guidelines: developed in collaboration with the international society for heart and lung transplantation. Circulation. 2009;119:1977–2016.PubMedCrossRefGoogle Scholar
29. 29.
    Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, et al. Effects of extended-release metoprolol succinate in patients undergoing noncardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371(9627):1839.PubMedCrossRefGoogle Scholar
30. 30.
    Devereaux PJ, Beattie WS, Choi PT, Badner NH, Guyatt GH, Villar JC, et al. How strong is the evidence for the use of perioperative beta blockers in noncardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ. 2005;331(7512):313.PubMedCrossRefGoogle Scholar
31. 31.
    Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001–7.Google Scholar
32. 32.
    The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II). Lancet. 1999;353:9–13.Google Scholar
33. 33.
    American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine, Society for Vascular Surgery, Fleischmann KE, Beckman JA, Buller CE, Calkins H, Fleisher LA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade. J Am Coll Cardiol. 2009;54(22):2102.PubMedCrossRefGoogle Scholar
34. 34.
    Khan NA, Campbell NR, Frost SD, Gilbert K, Michota FA, Usmani A, et al. Risk of intraoperative hypotension with loop diuretics: a randomized controlled trial. Am J Med. 2010;123:1059.e1–e8.CrossRefGoogle Scholar
35. 35.
    Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, et al. The use of subcutaneous eryropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35:1737–44.PubMedCrossRefGoogle Scholar
36. 36.
    Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, et al. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol. 2006;48:2485–9.PubMedCrossRefGoogle Scholar
37. 37.
    Weber CS, Beck-da-Silva L, Goldraich LA, Biolo A, Clausell N. Anemia in heart failure: association of hepcidin levels to iron deficiency in stable outpatients. Acta Haematol. 2012;129:55–61.PubMedCrossRefGoogle Scholar
38. 38.
    Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol. 2001;37:1775–80.PubMedCrossRefGoogle Scholar
39. 39.
    Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348:1055–60.PubMedCrossRefGoogle Scholar
40. 40.
    Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients I the intensive care unit. Crit Care Med. 1993;21:860–6.PubMedCrossRefGoogle Scholar
41. 41.
    Sowade O, Warnke H, Scigalla P, Sowade B, Franke W, Messinger D, et al. Avoidance of allogenic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood. 1997;89:411–8.PubMedGoogle Scholar
42. 42.
    Kiyama H, Ohshima N, Imazeki T, Yamada T. Autologous blood donation with recombinant human erythropoietin in anemic patients. Ann Thorac Surg. 1999;68:1652–6.PubMedCrossRefGoogle Scholar
43. 43.
    Cladellas M, Farre N, Comin-Colet J, Gomez M, Merono O, Bosch A, et al. Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. Am J Cardiol. 2012;110:1021–6.PubMedCrossRefGoogle Scholar
44. 44.
    Practice guidelines for blood component therapy: a report by the American society of anesthesiologists task force on blood component therapy. Anesthesiology. 1996;84:732–47.Google Scholar
45. 45.
    Tote SP, Grounds RM. Performing perioperative optimization of the high-risk surgical patient. Br J Anaesth. 2006;97:4–11.PubMedCrossRefGoogle Scholar
46. 46.
    Shoemaker WC, Appel PL, Kram HB. Hemodynamic and oxygen transport responses in survivors and nonsurvivors of high-risk surgery. Crit Care Med. 1993;21:977–90.PubMedCrossRefGoogle Scholar
47. 47.
    Roizen MF, Berger DL, Gabel RA, Gerson J, Mark JB, Parks RI, et al. Practice guidelines for pulmonary artery catheterization. Anesthesiology. 2003;99:988–1014.CrossRefGoogle Scholar
48. 48.
    Shoemaker WC, Appel PL, Kram HB. Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure. Crit Care Med. 1988;16:1117.PubMedCrossRefGoogle Scholar
49. 49.
    Binanay C, Califf RM, Hasselblad V, O’Connor CM, Shah MR, Sopko G, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005;294(13):1625.PubMedCrossRefGoogle Scholar
50. 50.
    Berlauk JF, Abrams JH, Gilmour IJ, O’Connor SR, Knighton DR, Cerra FB. Preoperative optimization of cardiovascular hemodynamics improves outcomes in peripheral vascular surgery. A prospective, randomized clinical trial. Ann Surg. 1991;214:289–99.PubMedCrossRefGoogle Scholar
51. 51.
    Bender JS, Smith-Meek MA, Jones CE. Routine pulmonary artery catheterization does not reduce morbidity and mortality of elective vascular surgery: results of a prospective, randomized trial. Ann Surg. 1997;226:229–36.PubMedCrossRefGoogle Scholar
52. 52.
    Kavarana MN, Azimuddin K, Agarwal A, Balsano N, Cayten CG, Agarwal N. Hemodynamic monitoring in the elderly undergoing elective colon resection for cancer. Am Surg. 2003;69:411–5.PubMedGoogle Scholar
53. 53.
    Lobo SMA, Salgado PF, Castillo VGT, Borim AA, Polachini CA, Palchetti JC, et al. Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med. 2000;28:3396–404.PubMedCrossRefGoogle Scholar
54. 54.
    Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, et al. A randomized, controlled trial of the use of pulmonary-artery catheter in high-risk surgical patients. NEJM. 2003;348:5–14.PubMedCrossRefGoogle Scholar
55. 55.
    Shayani V, Watson WC, Mansour MA, Thomas N, Pickleman J. Intra-aortic balloon counterpulsation in patients with severe cardiac dysfunction undergoing abdominal operations. Arch Surg. 1998;133:632–5.PubMedCrossRefGoogle Scholar
56. 56.
    Siu SC, Kowalchuk GJ, Welty FK, Benotti PN, Lewis SM. Intra-aortic balloon counterpulsation support in the high-risk cardiac patient undergoing urgent noncardiac surgery. Chest. 1991;99:1342–5.PubMedCrossRefGoogle Scholar
57. 57.
    Christopherson R, Beattie C, Frank SM, Norris EJ, Meinert CL, Gottlieb SO, et al. Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. Anesthesiology. 1993;79:422–34.PubMedCrossRefGoogle Scholar
58. 58.
    Barbosa FT, Cavalcante JC, Juca MJ, Castro AA. Neuraxial anaesthesia for lower-limb revascularization. Cochrane Database Syst Rev. 2010;(1):CD007083.Google Scholar
59. 59.
    Park WY, Thompson JS, Lee KK. Effect of epidural anesthesia and analgesia on perioperative outcome: a randomized, controlled Veterans Affairs cooperative study. Ann Surg. 2001;234(4):560.PubMedCrossRefGoogle Scholar
60. 60.
    Stundner O, Chiu YL, Sun X, Mazumdar M, Fleischut P, Poultsides L, et al. Comparative perioperative outcomes associated with neuraxial versus general anesthesia for simultaneous bilateral total knee arthroplasty. Reg Anesth Pain Med. 2012;37(6):638–44.PubMedCrossRefGoogle Scholar
61. 61.
    Mauermann WJ, Shilling AM, Zuo Z. A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis. Anesth Analg. 2006;103:1018–25.PubMedCrossRefGoogle Scholar
62. 62.
    Rodgers A, Walker N, Schug S, McKee A, Kehlet H, van Zundert A, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomized trials.Google Scholar
63. 63.
    Grailey K, Marker SR, Karthikesalingam A, Aboud R, Ziprin P, Faiz O. Laprascopic versus open colorectal resection in the elderly population. Surg Endosc. 2012. (epub ahead of print).Google Scholar
64. 64.
    Cox MR, McCall JL, Toouli J, Padbury RT, Wilson TG, Wattchow DA, et al. Prospective randomized comparison of open versus laparoscopic appendectomy in men. World J Surg. 1996;20(3):263–6.PubMedCrossRefGoogle Scholar
65. 65.
    Brunt LM. The positive impact of laparoscopic adrenalectomy on complications of adrenal surgery. Surg Endosc. 2002;16(2):252–7.PubMedCrossRefGoogle Scholar
66. 66.
    El Sahwi KS, Hooper C, De Leon MC, Gallo TN, Ratner E, Silasi DA, et al. Comparison between 155 robotic vs. 150 open surgical staging for endometrial cancer. Gynecol Oncol. 2012;124(2):260–4.CrossRefGoogle Scholar
67. 67.
    Robinson CN, Balentine CJ, Marshall CL, Wilks JA, Artinyan A, Berger DH, et al. Minimally invasive surgery improves short-term outcome in elderly colorectal cancer patients. J Surg Res. 2011;166(2):182–8.PubMedCrossRefGoogle Scholar
68. 68.
    Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. HM II BTT trial. N Engl J Med. 2007;357:885–96.PubMedCrossRefGoogle Scholar
69. 69.
    Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. NEJM. 2009;361:2241–51.PubMedCrossRefGoogle Scholar
70. 70.
    Morgan JA, Paone G, Nemeh HW, Henry SE, Gerlach B, Williams CT, et al. Noncardiac surgery in patients on long-term left ventricular assist device support. J Heart Lung Transplant. 2012;31:757–63.PubMedCrossRefGoogle Scholar
71. 71.
    Boyle AJ, Russell SD, Teuteberg JJ, Slaughter MS, Moazami N, Pagani FD, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant. 2009;28:881–7.PubMedCrossRefGoogle Scholar
72. 72.
    Ledford ID, Labedi M, Kfoury AG, Stehlik J, Alharethi R, Reid BB, et al. 235 Thombus within the HeartMate II Left Ventricular Assist Device (LVAD): are all clots created equal. J Heart Lung Transplant. 2012;31:S85–6.CrossRefGoogle Scholar
73. 73.
    Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, et al. Clinical management of continous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29:S1–S39.PubMedCrossRefGoogle Scholar